Dana Farber Cancer Institute at Merrimack Valley is a clinical research site located in Methuen, Massachusetts, United States 01844.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Dana Farber Cancer Institute at Merrimack Valley has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Monoclonal Gammopathy of Undetermined Significance (MGUS), Myelodysplastic Syndromes, Hematological Malignancies.
Sponsors: Dana-Farber Cancer Institute.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Dana Farber Cancer Institute at Merrimack Valley has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Dana Farber Cancer Institute at Merrimack Valley has 1 clinical trials on record, with 1 currently active. Their work covers Monoclonal Gammopathy of Undetermined Significance (MGUS), Myelodysplastic Syndromes, Hematological Malignancies.
Dana Farber Cancer Institute at Merrimack Valley has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.